BACKGROUND Supraclavicular block provides anaesthesia for upper extremity in the most consistent andf efficient manner of any brachial plexus technique. Adjuvants when added to local anaesthetics enhance the onset and prolongs the duration of block. α2 agonists produce analgesia, sympatholysis and sedation, hence considered as effective adjuvant.
analgesia, but without producing any major adverse effects. The α2 agonists Clonidine and Dexmedetomidine have shown potentials as an adjuvant along with local anaesthetics.
This current study is designed to test the hypothesis that dexmedetomidine when added as an adjuvant to mixture of 0.5% bupivacaine and 2% lignocaine with adrenaline in brachial plexus block enhances the onset, prolongs duration of sensory and motor block and duration of analgesia as compared with clonidine without causing any major haemodynamic instability or any other systemic side effects.
MATERIALS AND METHODS
A randomised controlled trial was conducted in a tertiary care hospital after approval of the Institutional Ethics Committee. (No.2015/P-I-RP/116) Patients with American Society of Anesthesiologist Grade I or II status, between 14 and 60 years of either gender, posted for upper limb surgery were included in the present study. Patients who refused to give informed consent, obese and short neck patients, patients with coagulopathy, neuropathy or local infection at the site for block, those with a history of allergy to the study drug or of drug abuse and an anticipated operative time more than 2 h were excluded from the study.
Preoperative Preparation
On the day of pre-anaesthetic evaluation, informed written consent was obtained in their mother tongue. Patients were fasted overnight. Tab. alprazolam 0.5 mg and Tab. ranitidine 150 mg was given orally the night before surgery.
Method of Collection of Data
Sixty patients were divided randomly into two groups (Group C, n= 30 and Group D, n= 30) using a computer-generated programme. Assigned random group was enclosed in a sealed envelope to ensure concealment of allocation sequence. The anaesthesiologist who was not involved in the study, opened the envelope in operation theatre and prepared the drug accordingly. Observations were done by the anaesthesiologist who was blinded to the drug. Intravenous access was secured with 18-G cannula on the contralateral arm. Patients were monitored for Heart rate, SpO2, non-invasive blood pressure and 3 lead ECG. All patients received supraclavicular brachial plexus block by an experienced anaesthesiologist who was blinded to the grouping.
Efficacy Assessment
The Effects of Anaesthetics on the following Parameters were observed-1. Sensory block was evaluated by Hollmen scale and findings were recorded at an interval of every 2 mins from time-0 till complete sensory block is achieved i.e. Hollmen Score= 4. 4. The duration of analgesia was the time when the patients received the first dose of analgesic when visual analogue scale was 4.
Hollmen Scale

Visual Analogue Scale (VAS)
5. Duration of sensory and motor block was assessed every 30 minutes for first 2 hours, every 60 minutes for next 4 hours and then at 9, 12, 18 and 24 hours. 6. Complications like inadequacy of block, any reaction at injection site like haematoma, persistent bradycardia, persistent hypotension, over sedation (sedation score >4), any respiratory distress, fall in respiratory rate to <10 per min, fall in SpO2 to < 90%, any significant ECG changes and Horner's syndrome were noted.
The above assessments were carried out by the principal investigator who was blinded to the drugs administered.
Sample size calculation was based on an initial study done by Kavitha Jinjil et al (International Journal of Health Care and Biomedical Research, volume: 3, issue: 3, April, 2015) with duration of analgesia as the primary end point of the study. With  error of 0.05 and power of the study (1-β) at 80%, to detect a minimum of 50 mins difference in duration of analgesia between the two groups, the sample size was calculated to be approximately 27 in each group. We included thirty patients in each group to compensate for possible dropouts. The patients who were part of the pilot study were not included in the study. Data was analysed using IBM-SPSS software (SPSS Statistics for Windows, Version 17.0, Chicago: SPSS Inc.). The patients' data and characteristics, the time of onset and duration of the block were categorised and analysed appropriately using student's unpaired t-test and Chi-square test. AP < 0.05 was considered as statistically significant and a p < 0.001 as statistically highly significant.
RESULTS
There was no significant difference in the patient's characteristics like age, sex, weight and ASA physical status, (Table 1) .
The haemodynamic parameters like heart rate, systolic and diastolic blood pressure and oxygen saturation in both the groups were comparable without any statistical significance. The sedation score were also comparable in both the groups without any statistical significance. The statistical analysis of the data in Table 2 by student's unpaired 't' test showed onset time of sensory and motor block, time of complete sensory and motor block, total duration of sensory and motor block and duration of analgesia in Group D was very highly significant in comparison to Group C with p value < 0.001.
Group C (n=30) Group D (n=30) P value
DISCUSSION
The α2 adrenoceptor agonists have been used either alone or in conjunction with local anaesthetics to prolong the duration of analgesia and to improve the quality of the block. 2-3 In our study, we have compared clonidine and dexmedetomidine as an adjuvant to local anaesthetics in supraclavicular brachial plexus block.
Clonidine has been used in doses between 0.5 to 1.5 μg/kg in brachial block (Elliott et al, 2 Singelyn et al 3 ). In our study we chose dose of 1 μg/kg, as no added benefits were found with doses exceeding 1.5 μg/kg. Clonidine increases duration of sensory and motor block of lignocaine by inhibition of evoked potential in C-fibre. We used same dose for dexmedetomidine as clonidine, i.e. 1 µg/kg so that both drugs can be compared.
In the present study combination of Lignocaine and Bupivacaine was used for early onset, prolong duration of block and lower the dose of individual drug, thereby reducing incidence of side effects. 4 We found that the onset and time for complete sensory block were significantly faster in the dexmedetomidine group (Group D) when compared to the clonidine group (Group C). Onset of motor block was also significantly early in Group D. Similar observations were noted in studies by Kavitha Jinjil et al 5 and Don Sebastian et al. 6 The total duration of sensory and motor block were also significantly longer in Group D in our study. Similar to observations by Swami SS et al, 7 Marhofer D et al, 8 Harshvardhan HS 9 and Zhang et al. 10 However, dexmedetomidine was also associated with an increased incidence of side effects, such as bradycardia and hypotension.
Mechanisms proposed explaining the efficacy of dexmedetomidine in improving the quality and prolonging the duration of block are:
Vasoconstriction around the injection site. [11] [12] [13] Direct suppression of impulse propagation through neurons by blocking voltage gated K+ channels and thus causing membrane hyperpolarisation, thereby slowing or blockade of impulse conduction. [14] [15] Local release of enkephalin like substances. 16 Decrease in localised inflammatory mediators and increase in anti-inflammatory mediators. 17 Inhibition of nerve action potential (AP) conduction and thus have an enhanced local anaesthetic effect. 18 Blockade of sodium channels by local anaesthetics with membrane hyperpolarisation and reduction of calcium influx inhibiting neurotransmitter release in the presynaptic Cfibres by α2 agonists result in earlier onset of sensory and motor block. The concentration-dependent, reversible blockade of compound action potentials in peripheral nerve fibres by α2 agonists is more on C-fibres than Aδ-fibres. Dexmedetomidine also produces analgesia at supraspinal level by acting on locus coeruleus; at spinal level by inhibiting neurotransmitters at substantia gelatinosa of dorsal horn and inhibiting release of substance P.
Sedation with dexmedetomidine, akin to natural sleep is due to its action on locus coeruleus. In fact it promotes REM sleep and is known to produce "conscious and cooperative sedation."
